Background The Bacillus Calmette–Guérin (BCG) vaccine may confer cross‐protection against
viral diseases in adults. This study evaluated BCG vaccine cross‐protection in adults with …

… Visacri b , Luciana SB Dal Col a , Cristiane F. Giacomelli a , Patricia AF Leme a , Cristiane L.
Maia a , Patricia Moriel b … Buosi, FAV Dionato, LSB Dal Col, CF Giacomelli, KL Ferrari, et al. …

Aim: We previously published results of the BATTLE trial, showing that patients recently
infected with SARS-CoV-2 can benefit from receiving Bacillus Calmette-Guérin (BCG) with …

Bladder cancer (BC) is the 10th most common cancer worldwide, with about 0.5 million reported
new cases and about 0.2 million deaths per year. In this scoping review, we summarize …

Objectives Healthcare workers (HCWs) may have different response to Bacillus Calmette-Guérin
(BCG) vaccination due to previous occupational exposure to Mycobacterium particles. …

Introduction Heath care workers with direct (HCW-D) or indirect (HCW-A) patient contact
represent 4.2% to 17.8% of COVID-19 cases. We evaluate the temporal COVID-19 infection …

Purpose To develop a reliable tool that predicts which patients are most likely to be COVID-19
positive and which ones have an increased risk of hospitalization. Methods From …

… real value of iodonium salts for the cGMP 18 F-PET tracer manufacturing industry, and their
… GBq of [ 18 F]7 from 285 GBq of [ 18 F]fluoride, the routine production of [ 18 F]7 is currently …

Purpose Loss of brain synapses is an early pathological feature of Alzheimer’s disease. The
current study assessed synaptic loss in vivo with positron emission tomography and an 18F-…

Background Kinetic modeling of physiological function using imaging techniques requires
the accurate measurement of the time-activity curve of the tracer in plasma, known as the …